Table 1.
Main information about data.
Timespan | 2020 : 2021 |
Sources (Journals, Books, etc) | 221 |
Documents | 285 |
Average years from publication | 0.614 |
Average citations per documents | 5.909 |
Average citations per year per doc | 3.168 |
References | 8986 |
DOCUMENT TYPES | |
Article | 163 |
book chapter | 2 |
conference paper | 5 |
Editorial | 24 |
Letter | 16 |
Note | 14 |
Review | 59 |
short survey | 2 |
DOCUMENT CONTENTS | |
Keywords Plus (ID) | 1949 |
Author's Keywords (DE) | 717 |
AUTHORS | |
Authors | 1714 |
Author Appearances | 1748 |
Authors of single-authored documents | 26 |
Authors of multi-authored documents | 1688 |
AUTHORS COLLABORATION | |
Single-authored documents | 28 |
Documents per Author | 0.166 |
Authors per Document | 6.01 |
Co-Authors per Documents | 6.13 |
Collaboration Index | 6.57 |
Most Productive Authors | Authors | Articles | Authors | Articles Fractionalized |
---|---|---|---|---|
1 | LUC JGY | 3 | LIAO JM | 2.00 |
2 | TOROUS J | 3 | VOSE JM | 2.00 |
3 | ALLISON S | 2 | NAJAFI B | 1.50 |
4 | ALVISI P | 2 | FISCHER SH | 1.25 |
5 | ANITESCU M | 2 | LUC JGY | 1.17 |
6 | ARMSTRONG WS | 2 | BERLIN J | 1.00 |
7 | BASTIAMPILLAI T | 2 | BHAVNANI SP | 1.00 |
8 | BECKER SJ | 2 | EGAN K | 1.00 |
9 | BLOEM BR | 2 | HREVTSOVA RY | 1.00 |
10 | BRANCOLINI S | 2 | IP-JEWELL S | 1.00 |
Top manuscripts per citations | |
---|---|
1 | SINGH AK, 2020, DIABETES METAB SYNDR CLIN RES REV |
2 | TOROUS J, 2020, JMIR MENT HEAL |
3 | DEDEILIA A, 2020, IN VIVO |
4 | FISK M, 2020, J MED INTERNET RES |
5 | BARNEY A, 2020, J ADOLESC HEALTH |
6 | CRAWFORD A, 2020, J MED INTERNET RES |
7 | O'CONNOR CM, 2020, J ARTHROPLASTY |
8 | BADAWY SM, 2020, JMIR PEDIATR PARENT |
9 | YELLOWLEES P, 2020, PSYCHIATR SERV |
10 | SAMUELS EA, 2020, J ADDICT MED |
DOI | TC | TCperYear | NTC | |
---|---|---|---|---|
1 | 10.1016/j.dsx.2020.04.004 | 187 | 93.5 | 20.95 |
2 | 10.2196/18848 | 171 | 85.5 | 19.16 |
3 | 10.21873/invivo.11950 | 85 | 42.5 | 9.52 |
4 | 10.2196/19264 | 60 | 30.0 | 6.72 |
5 | 10.1016/j.jadohealth.2020.05.006 | 48 | 24.0 | 5.38 |
6 | 10.2196/19361 | 42 | 21.0 | 4.71 |
7 | 10.1016/j.arth.2020.04.038 | 39 | 19.5 | 4.37 |
8 | 10.2196/20049 | 38 | 19.0 | 4.26 |
9 | 10.1176/appi.ps.202000230 | 37 | 18.5 | 4.15 |
10 | 10.1097/ADM.0000000000000685 | 35 | 17.5 | 3.92 |
Corresponding Author's Countries | Country Articles | Freq | SCP | MCP | MCP_Ratio |
---|---|---|---|---|---|
1 | USA | 113 0.4913 | 99 | 14 | 0.124 |
2 | UNITED KINGDOM | 16 0.0696 | 10 | 6 | 0.375 |
3 | AUSTRALIA | 14 0.0609 | 11 | 3 | 0.214 |
4 | CANADA | 12 0.0522 | 6 | 6 | 0.500 |
5 | ITALY | 11 0.0478 | 8 | 3 | 0.273 |
6 | INDIA | 8 0.0348 | 7 | 1 | 0.125 |
7 | IRELAND | 6 0.0261 | 6 | 0 | 0.000 |
8 | FRANCE | 5 0.0217 | 2 | 3 | 0.600 |
9 | SINGAPORE | 5 0.0217 | 4 | 1 | 0.200 |
10 | GERMANY | 4 0.0174 | 4 | 0 | 0.000 |
Total Citations per Country | Country | Total Citations | AverageArticle Citations |
---|---|---|---|
1 | USA | 686 | 6.07 |
2 | UNITED KINGDOM | 138 | 8.62 |
3 | CANADA | 82 | 6.83 |
4 | ITALY | 77 | 7.00 |
5 | SINGAPORE | 46 | 9.20 |
6 | IRELAND | 33 | 5.50 |
7 | AUSTRALIA | 32 | 2.29 |
8 | INDIA | 30 | 3.75 |
9 | NEW ZEALAND | 27 | 13.50 |
10 | MALAYSIA | 24 | 12.00 |
Most Relevant Sources | Sources | Articles |
---|---|---|
1 | JOURNAL OF MEDICAL INTERNET RESEARCH | 9 |
2 | JOURNAL OF SUBSTANCE ABUSE TREATMENT | 6 |
3 | JOURNAL OF GENERAL INTERNAL MEDICINE | 5 |
4 | INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH | 4 |
5 | ASIAN JOURNAL OF PSYCHIATRY | 3 |
6 | FRONTIERS IN PUBLIC HEALTH | 3 |
7 | INFLAMMATORY BOWEL DISEASES | 3 |
8 | JMIR MENTAL HEALTH | 3 |
9 | JMIR RESEARCH PROTOCOLS | 3 |
10 | JOURNAL OF ADDICTION MEDICINE | 3 |
Most Relevant Keywords | Author Keywords (DE) | Articles | Keywords-Plus (ID) | Articles |
---|---|---|---|---|
1 | COVID-19 | 129 | TELEMEDICINE | 352 |
2 | TELEMEDICINE | 73 | HUMAN | 242 |
3 | TELEHEALTH | 47 | PANDEMIC | 239 |
4 | PANDEMIC | 28 | HUMANS | 208 |
5 | DIGITAL HEALTH | 17 | BETACORONAVIRUS | 170 |
6 | INNOVATION | 15 | CORONAVIRUS DISEASE 2019 | 160 |
7 | SARS-COV-2 | 13 | PANDEMICS | 144 |
8 | CORONAVIRUS | 12 | PROCEDURES | 115 |
9 | MENTAL HEALTH | 8 | ORGANIZATION AND MANAGEMENT | 114 |
10 | ARTIFICIAL INTELLIGENCE | 7 | COVID-19 | 110 |